CPC C12Q 1/6883 (2013.01) [G01N 33/6881 (2013.01); G01N 33/6893 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/172 (2013.01); G01N 2500/04 (2013.01); G01N 2800/065 (2013.01); G01N 2800/205 (2013.01); G01N 2800/50 (2013.01)] | 15 Claims |
1. A method for reducing the risk of psoriasis in a human, the method comprising:
a) testing nucleic acid from said human for a polymorphism in gene IL13 as represented by position 101 of SEQ ID NO:22 or its complement by contacting said nucleic acid with an oligonucleotide that specifically hybridizes to C at said position 101 of SEQ ID NO:22 or G at said complement;
b) detecting said C or said G;
c) identifying said human as having an increased risk for psoriasis due to the presence of said C or said G; and
d) administering a therapeutic agent suitable for prevention or treatment of psoriasis to said human.
|